Network integration of multi-tumour omics data suggests novel targeting strategies

Area of Science:

• Oncology
• Genomics
• Pharmacology

Background:

• Identifying common drug targets across multiple tumor types is crucial for efficient cancer therapy development.
• Drug repurposing and novel combination strategies offer promising avenues for overcoming treatment resistance.

Purpose of the Study:

• To characterize diverse tumor types for identifying multi-tumor drug targets.
• To explore drug repurposing and novel combination therapies for cancer treatment.

Main Methods:

• Transcriptomic correlation profiling of 11 tumor types from The Cancer Genome Atlas (TCGA).
• Network-based analysis integrating gene expression and protein interaction data.
• Validation of identified signatures using mutational, pharmacological, and clinical evidence.

Main Results:

• Three distinct tumor clusters were identified based on transcriptomic profiles.
• Cluster-specific signatures involve key biological processes like NF-κB signaling, chromosomal instability, and apoptosis.
• In vitro experiments validated novel pharmacological strategies, showing synergistic effects on cell growth inhibition.

Conclusions:

• The study provides a list of potential multi-tumour drug targets and pathways for novel therapeutic strategies.
• Identified gene signatures and validated drug combinations can inform the design of new cancer treatments.
• Findings support the use of identified targets and pathways, individually or in combination, for future drug development.